Similar articles

• Evaluating localized prostate cancer and identifying candidates for focal therapy.

  Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT. Sartor AO, et al. Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004. Urology. 2008. PMID: 19095124
• Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.

  Meiers I, Waters DJ, Bostwick DG. Meiers I, et al. Urology. 2007 Dec;70(6 Suppl):3-8. doi: 10.1016/j.urology.2007.06.1129. Urology. 2007. PMID: 18194709
• Innovations in prostate biopsy strategies for active surveillance and focal therapy.

  Ukimura O, Hung AJ, Gill IS. Ukimura O, et al. Curr Opin Urol. 2011 Mar;21(2):115-20. doi: 10.1097/MOU.0b013e3283435118. Curr Opin Urol. 2011. PMID: 21178631 Review.
• What is the future of prostate-specific antigen for the early detection of prostate cancer?

  Getzenberg R. Getzenberg R. BJU Int. 2008 Jul;102(2):157-8. doi: 10.1111/j.1464-410X.2008.07694.x. Epub 2008 Jul 1. BJU Int. 2008. PMID: 18476972 No abstract available.
• MR-guided interventions of the prostate gland.

  Zangos S, Eichler K, Thalhammer A, Schoepf JU, Costello P, Herzog C, Mack MG, Vogl TJ. Zangos S, et al. Minim Invasive Ther Allied Technol. 2007;16(4):222-9. doi: 10.1080/13645700701520669. Minim Invasive Ther Allied Technol. 2007. PMID: 17763096 Review.